5-methoxy-2-methylamino-benzenethiol | 7110-88-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 5-methoxy-2-methylamino-benzenethiol
• 英文别名: N-Methyl-2-amino-5-methoxy-thiophenol；5-Methoxy-2-(methylamino)benzenethiol
• CAS: 7110-88-5
• 化学式: C₈H₁₁NOS
• 分子量: 169.247
• InChiKey: MYRGJOUAVOSZOA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  22.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-methoxy-2-methylamino-benzenethiol 在 吡啶 、 氨 作用下， 以 水 为溶剂， 生成 6,6'-dimethoxy-3,3'-dimethyl-3H,3'H-2,2'-ethanediylidene-bis-benzothiazole
  参考文献：
  名称：

  Kiprianow,A.I. et al., Journal of Organic Chemistry USSR (English Translation), 1966, vol. 2, p. 553 - 558

  摘要：

  DOI：

文献信息

• COMPOUNDS HAVING A POTENTIATING EFFECT ON THE ACTIVITY OF ETHIONAMIDE AND USES THEREOF
  申请人：Deprez Benôit

  公开号：US20110136823A1

  公开（公告）日：2011-06-09

  The present invention relates to the use of compounds with a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, for the preparation of a medicament for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy, to pharmaceutical compositions comprising them in combination with an antibiotic that is activatable via the EthA pathway, to compounds having a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, to pharmaceutical compositions comprising them and to their use as medicaments, especially medicaments for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy.

  本发明涉及具有增强抗生素活性的化合物，这些抗生素通过EthA酶途径可激活，用于制备预防和/或治疗如结核病和麻风病等分枝杆菌感染的药物；涉及包含这些化合物与通过EthA途径可激活的抗生素组合的药物组合物；涉及具有增强通过EthA酶途径可激活抗生素活性的化合物；涉及包含这些化合物的药物组合物；以及涉及它们作为药物，特别是用于预防和/或治疗如结核病和麻风病等分枝杆菌感染的药物的使用。
• [EN] TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM<br/>[FR] ESPÈCE D'ALPHA-SYNUCLÉINE ABERRANTE CIBLÉE ET UBIQUITINATION INDUITE ET CLAIRANCE PROTÉOSOMIQUE PAR CO-RECRUTEMENT D'UN SYSTÈME E3-LIGASE
  申请人：DANA FARBER CANCER INST INC

  公开号：WO2021257650A1

  公开（公告）日：2021-12-23

  Disclosed are bispecific compounds (degraders) that target α-synuclein protein for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat neurodegenerative diseases.

  揭示了一种针对α-突触核蛋白进行降解的双特异性化合物（降解剂）。还揭示了含有这些降解剂的药物组合物以及利用这些化合物治疗神经退行性疾病的方法。
• Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
  申请人：McDonald Ivar M.

  公开号：US20110269787A1

  公开（公告）日：2011-11-03

  The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

  本发明提供了公式I的化合物，包括其盐，以及使用这些化合物的组合物和方法。这些化合物是尼古丁α7受体的配体，可能对中枢神经系统的各种疾病，特别是情感和神经退行性疾病的治疗有用。
• AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE
  申请人：Shanghai Jemincare Pharmaceuticals Co., Ltd.

  公开号：EP3892616A1

  公开（公告）日：2021-10-13

  Relating to a compound represented by formula (I) and a pharmaceutically acceptable salt of the compound, and an application of the compound as an S1P1 agonist.

  涉及一种由式 (I) 代表的化合物和该化合物的药学上可接受的盐，以及该化合物作为 S1P1 激动剂的应用。
• Anthelmintic quaternary salts. III. Benzothiazolium salts
  作者：David L. Garmaise、Gerard Y. Paris、Jacqueline Komlossy、C. H. Chambers、R. C. McCrae

  DOI：10.1021/jm00301a008

  日期：1969.1